Cargando…

Adrenal function in patients receiving rifampin-based anti-tuberculosis regimens: A cross-sectional study in Iran

Detalles Bibliográficos
Autores principales:	Jafari, Sirous, Behjati, Javad, Shafaei, Kaveh, Dehghan Manshadi, Seyed Ali, Seifi, Arash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911767/ https://www.ncbi.nlm.nih.gov/pubmed/33680392 http://dx.doi.org/10.22088/cjim.11.4.458

Ejemplares similares

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
por: Huang, Yu-Tsung, et al.
Publicado: (2018)

Does an antimicrobial stewardship program for Carbapenem use reduce Costs? An observation in Tehran, Iran
por: Hajiabdolbaghi, Mahboubeh, et al.
Publicado: (2020)

Bilateral septic arthritis of the knee caused by group B streptococci: a case report
por: Manshadi, Seyed Ali Dehghan, et al.
Publicado: (2019)

Knowledge and perception of hand hygiene: A survey using WHO standardized tools in Tehran, Iran
por: Dehghan Manshadi, Seyed Ali, et al.
Publicado: (2022)

Determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection: largest medical center in Iran
por: Mohammadnejad, Esmaeil, et al.
Publicado: (2023)

FRI215 Rifampin Induced Adrenal Insufficiency
por: Campbell, Spencer Ramon, et al.
Publicado: (2023)

Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide
por: Kim, Joo-Hee, et al.
Publicado: (2010)

Discordance in Mycobacterium tuberculosis Rifampin Susceptibility
por: Kalokhe, Ameeta S., et al.
Publicado: (2012)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
por: Sirous, Mehrandokht, et al.
Publicado: (2018)

S1.1d Risk factors associated with oropharyngeal candidiasis in COVID-19 patients: a case control study
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

191. High-Dose Rifampin-containing Regimens for the Treatment of TB Meningitis
por: Ruiz-Bedoya, Camilo A, et al.
Publicado: (2021)

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
por: Sam, I-Ching, et al.
Publicado: (2006)

Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report
por: Fahmi, Amr Mohamed, et al.
Publicado: (2016)

Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis
por: Said, Bibie N, et al.
Publicado: (2021)

Post-neurosurgical meningitis; gram negative bacilli vs. gram positive cocci
por: Zeinalizadeh, Mehdi, et al.
Publicado: (2022)

Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran
por: Tajbakhsh, Amir, et al.
Publicado: (2018)

Prevalence of nosocomial infections in Covid-19 patients admitted to the intensive care unit of Imam Khomeini complex hospital in Tehran
por: Mohammadnejad, Esmaeil, et al.
Publicado: (2021)

Antimicrobial susceptibility testing of Staphylococcus aureus isolates from patients at a tertiary hospital in Tehran, Iran, 2018–2019
por: Qodrati, Mohammad, et al.
Publicado: (2022)

Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma
por: Jalali, Amir, et al.
Publicado: (2014)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Comparison of Rifabutin-Based Versus Rifampin-Based Regimens for the Treatment of Mycobacterium avium Complex: A meta-Analysis Study
por: Hajikhani, Bahareh, et al.
Publicado: (2021)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Mycobacterium tuberculosis Beijing Genotype Resistance to Transient Rifampin Exposure
por: den Hertog, Alice L., et al.
Publicado: (2014)

Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis
por: Sakamoto, Akio, et al.
Publicado: (2017)

Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
por: Thomas, Levin, et al.
Publicado: (2020)

rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
por: Li, Ma-chao, et al.
Publicado: (2021)

Etymologia: Rifampin
por: Henry, Ronnie
Publicado: (2018)

MON-355 Recurrent Adrenal Crisis Secondary to Rifampin-Induced Hepatic Microsomal Enzyme Metabolism
por: Yehya, Ahmad, et al.
Publicado: (2019)

Mutations of rpob Gene Associated with Rifampin Resistance among Mycobacterium Tuberculosis Isolated in Tuberculosis Regional Reference Laboratory in Northeast of Iran during 2015–2016
por: Tavanaee sani, Ashraf, et al.
Publicado: (2018)

Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial
por: Nourian, Anahid, et al.
Publicado: (2020)

Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis
por: Pourazar Dizaji, Shahin, et al.
Publicado: (2017)

Exploring the reasons for women to engage in sex work in Tehran, Iran: A qualitative study
por: Yoosefi Lebni, Javad, et al.
Publicado: (2021)

Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis
por: Loveday, Marian, et al.
Publicado: (2019)

Genotyping of rifampin-resistant Mycobacterium tuberculosis isolates from western Turkey
por: Cavusoglu, Cengiz, et al.
Publicado: (2004)

Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait
por: Mokaddas, Eiman, et al.
Publicado: (2005)

Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis
por: Sloan, Derek J., et al.
Publicado: (2017)

Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
por: Rabie, Helena, et al.
Publicado: (2020)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa
por: Leavitt, Sarah V., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4110krhoj7s8uj78iu0sm2o4i3